UAE bans ciprofloxacin for animals to combat antimicrobial resistanceThe UAE's drug authority, the Emirates Drug Establishment (EDE), has announced a ban on the veterinary use of ciprofloxacin, a type of antibiotic, starting November 1, 2026. The decision aims to address antimicrobial resistance, which threatens the effectiveness of antibiotics in human medicine. Ciprofloxacin belongs to the fluoroquinolone group, classified as Critically Important Antimicrobials (CIAs) due to its significance in treating bacterial infections in humans. The ban applies to veterinary medicinal products and raw materials containing ciprofloxacin, affecting both imported and locally registered products. Veterinary businesses must stop manufacturing, importing, and supplying these products, withdraw existing stock from the market, and either re-export or properly dispose of remaining supplies. EDE has initiated a monitoring plan to ensure compliance and has based its decision on research, including studies from the United Arab Emirates University. Officials emphasized the importance of scientific evidence in guiding regulatory actions to safeguard public health.
Bias read (Center): The article presents a factual report on a regulatory decision made by the UAE's drug authority to combat antimicrobial resistance. There is no evident ideological framing, biased language, or selective sourcing. The content focuses on public health policy and scientific justification, with balanced
UAE bans veterinary use of antibiotic in bid to tackle drug resistanceThe United Arab Emirates has announced a ban on the veterinary use of ciprofloxacin, an antibiotic, effective from November 1. This decision aims to combat antimicrobial resistance and protect the effectiveness of antibiotics in human medicine. Ciprofloxacin belongs to a critical class of antibiotics known as fluoroquinolones, which are essential for treating serious human infections like sepsis and pneumonia. The ban applies to nine products, both imported and locally registered, and requires affected businesses to cease production, importation, and distribution of these products while removing existing stock from the market. The move follows a scientific review of antimicrobial resistance data, including contributions from the United Arab Emirates University. The National Pharmaceuticals Regulator, the Emirates Drug Establishment, emphasized the importance of preserving antibiotic efficacy for human health and outlined plans to enforce compliance with the new restrictions.
Bias read (Center): The article presents a regulatory action taken by the UAE government aimed at addressing a public health concern, antimicrobial resistance. The content is factual, citing the Emirates Drug Establishment and referencing scientific assessments. There is no overt ideological framing, and the focus is on
AE
